These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15684637)

  • 21. Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.
    Pfützner A; Hermanns I; Ramljak S; Demircik F; Pfützner AH; Kann PH; Weber MM
    J Diabetes Sci Technol; 2015 Sep; 9(6):1307-12. PubMed ID: 26420624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control.
    Jain SK; Nagi DK; Slavin BM; Lumb PJ; Yudkin JS
    Diabet Med; 1993; 10(1):27-32. PubMed ID: 8435984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
    Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
    Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of fasting glucagon and proinsulin concentrations with insulin resistance.
    Ferrannini E; Muscelli E; Natali A; Gabriel R; Mitrakou A; Flyvbjerg A; Golay A; Hojlund K;
    Diabetologia; 2007 Nov; 50(11):2342-7. PubMed ID: 17846745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of insulin resistance in young women with polycystic ovary syndrome.
    Jensterle M; Weber M; Pfeifer M; Prezelj J; Pfutzner A; Janez A
    Int J Gynaecol Obstet; 2008 Aug; 102(2):137-40. PubMed ID: 18504045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pitfalls in the diagnosis and treatment optimization of type 2 diabetes].
    Pfützner A; Kerner W
    MMW Fortschr Med; 2005 Mar; 147(12):47-50. PubMed ID: 15832793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
    Matsuhisa M; Yamasaki Y; Emoto M; Shimabukuro M; Ueda S; Funahashi T; Matsuzawa Y
    Diabetes Res Clin Pract; 2007 Jul; 77(1):151-4. PubMed ID: 17081646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subgroup analysis of proinsulin and insulin levels reveals novel correlations to metabolic indicators of type 2 diabetes.
    Li T; Quan H; Zhang H; Lin L; Lin L; Ou Q; Chen K
    Aging (Albany NY); 2020 Jun; 12(11):10715-10735. PubMed ID: 32532930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma proinsulin in recently diagnosed type 2 diabetes mellitus.
    Schmidli RS; Hagan C; Scott RS; Livesey J; Forbes LV
    Diabetes Res Clin Pract; 1993 May; 20(2):133-8. PubMed ID: 8375266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
    Dorkhan M; Magnusson M; Frid A; Grubb A; Groop L; Jovinge S
    J Intern Med; 2006 Aug; 260(2):125-33. PubMed ID: 16882276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
    Pfützner A; Kann PH; Pfützner AH; Kunt T; Larbig M; Weber MM; Forst T
    Clin Lab; 2004; 50(9-10):567-73. PubMed ID: 15481632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proinsulin and age in general population.
    Ateia S; Rusu E; Cristescu V; Enache G; Cheța DM; Radulian G
    J Med Life; 2013; 6(4):424-9. PubMed ID: 24868254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes: what to add--insulin glargine or pioglitazone?
    Dorkhan M; Frid A; Groop L
    Diabetes Res Clin Pract; 2008 Dec; 82(3):340-5. PubMed ID: 18926586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exenatide versus glibenclamide in patients with diabetes.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Diabetes Technol Ther; 2010 Mar; 12(3):233-40. PubMed ID: 20151774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of adiponectin and leptin in children born small for gestational age: relation to insulin sensitivity parameters.
    Miras M; Ochetti M; Martín S; Silvano L; Sobrero G; Castro L; Onassis M; Tolosa de Talamoni N; Pérez A; Picotto G; Díaz de Barboza G; Muñoz L
    J Pediatr Endocrinol Metab; 2010 May; 23(5):463-71. PubMed ID: 20662345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
    Forst T; Pfützner A; Lübben G; Weber M; Marx N; Karagiannis E; Koehler C; Baurecht W; Hohberg C; Hanefeld M
    Metabolism; 2007 Apr; 56(4):491-6. PubMed ID: 17379006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.